This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More Than Half Of Nasal Allergy Sufferers Experience Sleep Issues, Yet Many Fail To Adequately Prepare In Advance Of Peak Allergy Seasons

LANDOVER, Md., April 23, 2013 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory released results today from a new survey which showed that more than half (59 percent) of nasal allergy sufferers polled reported sleep issues as a result of their allergy symptoms, yet only 35 percent proactively treat their nasal allergy symptoms.  Furthermore, nearly half of those surveyed (48 percent) said their nasal allergy symptoms, such as nasal congestion and sneezing, also interrupted their partner's sleep.

To view the multimedia assets associated with this release, please click:

(Photo: )

The survey is part of Ditch the Drip: Get Serious about Nasal Allergies , an educational program that features Misty May-Treanor, three-time Olympic beach volleyball gold medalist and nasal allergy sufferer. May-Treanor has teamed up with the program for the second year to elevate the seriousness of nasal allergies and educate the 60 million Americans suffering from nasal allergies about the need for proactive preparation in advance of peak allergy seasons. For more information on the survey findings and resources for those suffering from seasonal or year-round nasal allergies, visit

"I made the difficult decision to retire from international beach volleyball after the 2012 Olympic Games, but I still lead an incredibly active lifestyle," said Misty May-Treanor, Olympic athlete and Ditch the Drip spokesperson. "As I move into this next chapter of my life, I'm focused on spending quality time with my husband and pursuing both professional and educational goals, so suffering from bothersome nasal allergy symptoms just doesn't fit into my plans. By continuing my partnership with Ditch the Drip, I hope to show others that they don't have to miss out on doing the things they love just because they're suffering from nasal allergies. By being proactive about scheduling appointments with their doctors in advance of peak allergy seasons, people with allergies can avoid being sidelined by their pesky symptoms."

Beyond survey results related to sleep quality, additional findings include:
  • 57 percent of survey respondents noted they've experienced difficulty concentrating at work
  • 61 percent said they cannot enjoy the outdoors with their children as much as they would like due to their nasal allergies
  • 71 percent indicated they typically only treat their nasal allergies when they are experiencing symptoms or a flare-up

"This survey further reinforces that although many people are significantly impacted by their nasal allergies, they are doing very little to avoid the onset of their burdensome symptoms," said Bill McLin, President and CEO of AAFA. "As such, we are thrilled to continue our partnership with Misty and Teva Respiratory on the Ditch the Drip program to help provide people with nasal allergies with tools and resources they can use to better prepare for peak allergy seasons and nip their symptoms in the bud." 

Visit to view more survey findings and to learn more about Misty's struggle with seasonal allergies. Visitors can also enter for a chance to be one of four grand prize winners who will receive a certified asthma & allergy friendly™ Dyson vacuum and accompanying asthma & allergy kit.

About the Survey The Nasal Allergy Sufferers Survey was conducted by Manhattan Research on behalf of Teva Respiratory. The survey was conducted online and completed by 2,000 U.S. adults (age 18 and over) diagnosed with nasal allergies. The margin of error for the study is +/-2.2% at 95 percent confidence interval.

About Misty May-Treanor Misty May-Treanor is an American professional beach volleyball player and actress. She has won more tournaments than any other female player. Misty and her teammate were the gold medalists in beach volleyball at the 2004, 2008 and 2012 Summer Olympics. They are the only beach volleyball team to win gold medals in three Olympic Games in a row.

Misty has struggled with seasonal allergies for most of her life and is now committing time to educating other sufferers on how to better prepare for and manage allergies through her participation in the Ditch the Drip program.

About Allergic Rhinitis Allergic rhinitis (AR) is a chronic inflammatory disease characterized by symptoms such as itchy, runny nose, nasal congestion and sneezing. For many AR patients, nasal congestion or a stuffy nose may be the most frequent and bothersome symptom. AR is the most common allergic disease in the U.S., affecting between 10 to 30 percent of adults and 40 percent of children in the U.S.  AR can cause some sufferers to experience symptoms year round – perennial allergic rhinitis (PAR) – and others to have symptoms during specific times of the year – seasonal allergic rhinitis (SAR) – such as spring or fall.

About Asthma and Allergy Foundation of America The Asthma and Allergy Foundation of America (AAFA) is a not-for-profit organization founded in 1953 that serves as the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world. AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy and research. AAFA provides practical information, community-based services and support to people through a network of regional chapters, support groups and other local partners around the U.S. AAFA develops health education, organizes state and national advocacy efforts and funds research to find better treatments and cures. Visit

About Teva Respiratory Teva Respiratory is the U.S.-based respiratory subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE:  TEVA). Teva Respiratory's core focus on safety, quality and customers has produced some of the most successful treatment options for people with asthma, exercise-induced bronchospasm (EIB), chronic obstructive pulmonary disease (COPD), and seasonal and year-round nasal allergy symptoms.  For more information on Teva Respiratory and its products, visit


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs